Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2022-10-03
2022-11-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ECG Signal Collection From Long QT Syndrome, Wide QRS Complexes, Heart Failure, and Cardiac Resynchronization Patients
NCT00399412
Preliminary Research Evaluation for Ambulatory Leadless Electrocardiogram Recorder Trial
NCT05357716
Electrocardiogram (ECG) Guided Peripherally Inserted Central Catheter (PICC) Placement
NCT00742053
Dynamic Data-Driven Management of Atrial Fibrillation Using Implantable Cardiac Monitors: The MONITOR-AF Study
NCT06352060
Surface Electrocardiogram (ECG) Signal Recording for Implantable Subcutaneous String Defibrillator (ISSD) Development
NCT02991716
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
New electrodes
New package of electrodes
12 lead Electrocardiogram
12 lead Electrocardiogram
24-hour opened electrodes
Electrodes opened 24 hours
12 lead Electrocardiogram
12 lead Electrocardiogram
30 day opened electrodes
Electrodes opened 30 days
12 lead Electrocardiogram
12 lead Electrocardiogram
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
12 lead Electrocardiogram
12 lead Electrocardiogram
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: 29 days to 89 years
* Willing and able to provide informed consent and complete study procedures
* Willing to have Philips representatives present during study procedures.
Exclusion Criteria
* Any limitation or medical condition, including but not limited to physical or cognitive disability, that would affect the participant's ability to complete study activities (per investigator)
* At the time of enrollment, current enrollment in any other interventional research study
* An employee, or residing family member of an employee, of a company that designs, sells, or manufactures monitor/defibrillator technology or related products (including Philips)
29 Days
89 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Philips Clinical & Medical Affairs Global
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alaa El-Gendy, MD, MSc, FCCP
Role: PRINCIPAL_INVESTIGATOR
Lehigh Pulmonary Associates, PA (D/B/A Florida Lung & Sleep Associates)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lehigh Pulmonary Associates, PA (D/B/A Florida Lung & Sleep Associates)
Lehigh Acres, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCTCECRIntrepid 12Lead2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.